DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas will sit on a panel at the 2007 BIO International Convention titled "Mining for Gold: Top Biotech Venture Capital Markets" in Boston
News | 05. 06. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.